The forecast for antacid medicine use in Germany from 2024 to 2028 shows a stable trend with a slight increase. The consumption remains constant at 1.0 Units (Defined Daily Dosage) Per Thousand Persons Per Day from 2024 through 2026, increasing marginally to 1.1 in 2027 and continuing in 2028. Compared to 2023, where the values were recorded similar to the projected 2024 data, the market shows minimal year-on-year fluctuation, indicating steadiness.

Future trends to watch for:

Growing prevalence of gastrointestinal disorders due to dietary habits and lifestyle changes may influence antacid consumption.
Healthcare advancements and increasing consumer awareness might encourage alternative treatments, possibly impacting the antacid market dynamics.
Regulatory changes and healthcare policies in Germany could further affect the sector’s growth trajectory.